Moorthi, R.N., Moe, S.M., Recent advances in the noninvasive diagnosis of renal osteodystrophy. Kidney Int. 84 (2014), 886–894.
Delanaye, P., Warling, X., Moonen, M., Smelten, N., Jouret, F., Krzesinski, J.M., Maillard, N., Pottel, H., Cavalier, E., Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients. Sci. Rep. 7 (2017), 3–10.
Robling, A.G., Niziolek, P.J., Baldridge, L.A., Condon, K.W., Allen, M.R., Alam, I., Mantila, S.M., Gluhak-Heinrich, J., Bellido, T.M., Harris, S.E., Turner, C.H., Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J. Biol. Chem. 283 (2008), 5866–5875.
Cejka, D., Herberth, J., Branscum, A.J., Fardo, D.W., Monier-Faugere, M.C., Diarra, D., Haas, M., Malluche, H.H., Sclerostin and dickkopf-1 in renal osteodystrophy. Clin. J. Am. Soc. Nephrol. 6 (2011), 877–882.
Behets, G.J., Viaene, L., Meijers, B., Blocki, F., Brandenburg, V.M., Verhulst, A., D'Haese, P.C., Evenepoel, P., Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD. PLoS One 12 (2017), 1–12.
Delanaye, P., Paquot, F., Bouquegneau, A., Blocki, F., Krzesinski, J.-M., Evenepoel, P., Pottel, H., Cavalier, E., Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know. Nephrol. Dial. Transplant., 2017, 1–7.
Delanaye, P., Krzesinski, J.M., Warling, X., Moonen, M., Smelten, N., Médart, L., Bruyère, O., Reginster, J.Y., Pottel, H., Cavalier, E., Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients. Nephron. - Clin. Pract. 128 (2014), 127–134.
Cejka, D., Parada-Rodriguez, D., Pichler, S., Marculescu, R., Kramer, I., Kneissel, M., Groos, T., Reisinger, A., Pahr, D., Monier-Faugere, M.C., Haas, M., Malluche, H.H., Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease. Kidney 90 (2016), 828–834.
Qureshi, A.R., Olauson, H., Witasp, A., Haarhaus, M., Brandenburg, V., Wernerson, A., Lindholm, B., Söderberg, M., Wennberg, L., Nordfors, L., Ripsweden, J., Barany, P., Stenvinkel, P., Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification. Kidney Int. 88 (2015), 1356–1364.
Malluche, H.H., Davenport, D.L., Canto, T., Monier-Faugere, M.C., Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis. Clin. J. Am. Soc. Nephrol. 9 (2014), 1254–1262.
